18 Jul Astraveus
Jeremie Laurent, Ph.D., CEO
Oct. 7 | 3:15pm | FLW Ballroom G
Paris, France
(Private)
Founded 2016 in Paris by Jérémie Laurent (CEO), Astraveus aspires to radically reduce complexity and cost of cell therapy manufacturing, thereby making cell therapies more accessible to patients. Astraveus develops the Lakhesys Benchtop Cell Factory, a scalable, fully automated microfluidic platform for end-to-end cell therapy process development, clinical and commercial manufacturing. This revolutionary platform delivers unprecedented reduction of manufacturing footprint, labor and use of expensive process materials, leveraging proprietary microfluidic technology. The Lakhesys Benchtop Cell Therapy Factory enables parallelized and automated cell therapy processing in an end-to-end fashion, from cellular starting material to the final drug product, and provides integrated real-time quality control capabilities. Through this holistic approach, Astraveus minimizes process development effort and maximizes manufacturing output, thus enabling access to care for patients in need at a cost per dose as low as $15k.
